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The developing complementary technologies of DNA
microarrays and proteomics are allowing the response of
bacterial pathogens to different environments to be probed
at the whole genome level. Although using these technolo-
gies to analyze pathogens within a host is still in its infancy,
initial studies indicate that these technologies will be valu-
able tools for understanding how the pathogen reacts to the
in vivo microenvironment. Some bacterial pathogens have
been shown to substantially modify their surface compo-
nents in response to the host immune system and modify
their energy metabolism and transport pathways to allow
efficient growth within the host. Further detailed analyses of
these responses will increase understanding of the molec-
ular mechanisms of pathogenesis, identify new bacterial
virulence factors, and aid in the design of new vaccines.
H
ow do bacteria respond to the host environment during
an infection? Bacterial pathogens must be able to gain
access to, persist in, and replicate in normally privileged
sites within a host. Moreover, they must produce certain
factors that result in a level of host damage that perturbs
homeostasis. Thus, pathogens must have specific mecha-
nisms for mediating colonization, avoiding the host’s
immune system, and acquiring necessary nutrients. They
must also produce factors that result (directly or indirectly)
in host damage. Because the environment encountered
within a living host will be quite different from the external
environment, pathogens must be able to regulate the neces-
sary genes in coordination as they move from the environ-
ment to the host and from one host niche to another.
The primary aim of investigating bacterial pathogenesis
is to understand the way that pathogens interact with the
host to cause disease. Central to this investigation is an
understanding of what gene products are required and
expressed during a natural infection and how this expres-
sion changes over time (from initial colonization to causa-
tion of disease and spread of the pathogen to new hosts)
and space (in different cells or tissues within the host). We
thus endeavor to understand how the pathogen adapts to
the host microenvironment, what selective pressures are
acting on the pathogen in each microenvironment, what
bacterial factors are responsible for the host damage, and
how the immune system is evaded. Although analyses that
give information on the expression of a few genes provide
insight and have been responsible for a large proportion of
the bacterial pathogenesis literature currently available,
our ultimate goal is to understand expression changes
across the whole genome. The additional information gen-
erated by whole genome studies goes far beyond that
derived by characterizing in isolation more genes and gene
products, because analysis of the whole genome allows
complete regulatory networks to be identified and charac-
terized. These results cannot be achieved with a “one-
gene-at-a-time” approach. Whole genome studies could be
considered as an exponential and synergistic advance
rather than a linear progression. 
The host-pathogen interactions that define a disease are
clearly complex, and, in many cases, the study of these
interactions is limited by the lack of a suitable animal
model. However, we now have a number of methods that
allow identification of genes critical for survival in a host
as well as methods that allow direct measurement of gene
expression during interaction with a host. Two of these
methods, signature-tagged mutagenesis and in vivo
expression technology, do not directly measure gene
expression and do not allow true genomic-scale analysis,
but they have been devised to identify genes necessary for
pathogens during real infections. Excellent reviews on
these techniques are available (1,2), and they will not be
discussed in this review. A second group of methods,
which includes DNA microarrays and proteomics, have
advantages that overcome the limitations implicit in signa-
ture-tagged mutagenesis and in vivo expression technolo-
gy, namely, the ability to directly measure expression
(gene or protein) levels on a true genome-wide scale, but
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real infections is still in its infancy. Another method, real-
time reverse transcriptase polymerase chain reaction (RT-
PCR) has qualities that bridge those of the other methods,
allowing accurate gene expression measurements but on a
subgenomic scale; thus, we will not discuss it in this
review. However, real time RT-PCR is useful for coping
with the low numbers of microorganisms that are often
available during infections, and high-throughput whole-
genomic scale real-time RT-PCR may become available in
the near future. We summarize the current application of
DNA microarray and proteomics techniques to the under-
standing of how bacteria modify their expression profiles
within an infected host. 
DNA Microarray Studies
DNA microarrays offer the promise of accurate gene
expression measurements for every gene in a genome and
allow this expression to be analyzed in response to any
environmental variable. However, this huge potential for
the understanding of bacterial pathogenesis has not yet
been completely realized because of the substantial techni-
cal problems associated with accurately measuring bacter-
ial gene expression during real infections. The main
problems associated with their use in such situations
include the following: the low numbers of bacteria in liv-
ing tissues during infection, difficulty in purifying the bac-
teria (and therefore bacterial RNA) from the eukaryotic
tissue, potential mRNAinstability and possible differential
degradation during purification, and the difficulty in find-
ing an appropriate animal model for many diseases. The
instability of bacterial mRNA can in part be overcome by
using commercially available RNA stabilization reagents
such as RNAlater (Qiagen, Hilden, Germany).
Additionally, because of the specificity of DNAhybridiza-
tions, small amounts of co-purified eukaryotic RNA are
unlikely to adversely affect the microarray results.
However, this type of transcriptional analysis can current-
ly only be applied to those infections that lead to high titers
of infecting organisms in host tissues, since the experi-
ments require at least microgram quantities of RNA. Thus
far, no one has accurately measured gene expression
throughout an infection, from the initial stage of
invasion/colonization through multiplication and tissue
spread to the final stages of disease with notable host dam-
age. Such a complete analysis of gene expression remains
the “holy grail” of gene expression measurements with
regard to bacterial pathogenesis. However, we are begin-
ning to see a number of experiments that provide insights
into the way bacteria regulate gene expression at different
phases of infection.
The first wave of DNAmicroarray experiments of rele-
vance to bacterial pathogenesis focused on analyzing bac-
terial gene expression during growth in vitro under condi-
tions chosen to mimic some aspect of infection. In many
cases, the relationship to a specific condition that the bac-
teria will face during growth in the host is clear, and as the
conditions are manipulated in vitro, the test conditions can
be tightly controlled. Thus, these studies have allowed a
detailed description of bacterial pathogen response to iron
limitation (3,4), nutrient limitation (5,6), acidic environ-
ments (7,8), low oxygen (9,10), bacterial density (11,12),
and biofilm formation (11,12). A number of studies have
also analyzed the global effects of transcriptional regula-
tors with the aim of defining complete regulatory networks
(13). 
Although the in vitro experiments have added substan-
tially to our understanding of gene expression in bacterial
pathogens, they can never completely model the condi-
tions that a pathogen encounters in a host during infection.
Thus, the second wave of microarray experiments has
focused on directly measuring bacterial gene expression
during interaction with eukaryotic cells or during growth
within the host (Table). Three studies have directly ana-
lyzed whole-genome bacterial gene expression during
growth in the tissues of a living eukaryotic host (18–20),
while a fourth analyzed gene expression in bacteria recent-
ly exited from host tissue, the lumen of the bowel (21). All
four experiments compared growth in vivo with growth in
in vitro laboratory medium. Three of the studies carried out
competitive hybridization of in vivo and in vitro RNA to
directly compare gene expression in the two sites, whereas
the third study compared gene expression levels of both in
vivo and in vitro samples to a common reference sample
(genomic DNA). Despite the analyses being carried out on
different bacterial species (Vibrio cholerae and Pasteurella
multocida), striking similarities between the gene expres-
sion changes were seen in all four experiments. 
All experiments showed a substantial up-regulation of
genes involved in amino acid metabolism, purine biosyn-
thesis, and iron transport and metabolism. Genes in the ilv
and pur operons were consistently up-regulated. Many of
the changes also involved up-regulation of genes involved
in transport of amino acids and carbohydrates. Indeed, a
large number of ABC transport systems were measured as
up-regulated. Therefore, in the in vivo environment,
whether in rabbit ileal loops, blood, liver, or rice water
stools, available nutrients are markedly reduced compared
with those in the in vitro medium. Although the current
studies have compared gene expression with growth in rich
in vitro medium, the major reason for this approach has
been the desire to identify potential virulence genes rather
that those up-regulated in vivo simply in response to the in
vivo nutritional environment. However, many of these
genes have been identified by signature-tagged mutagene-
sis studies as necessary for in vivo survival (25–27).
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involved in energy metabolism were up-regulated during
growth in vivo. Specifically, in each experiment some of
the highest up-regulated genes included those encoding
particular alternative electron acceptor complexes. In both
V. cholerae, purified from rice water stools, and P. multo-
cida, purified from the blood of chickens, the nap
(periplasmic nitrate reductase) operon was highly up-regu-
lated. In V. cholerae, grown in rabbit ileal loops, the frd
(fumarate reductase) operon was up-regulated, and in P.
multocida, purified from the livers of chickens, the dms
(dimethyl sulfoxide reductase) operon was up-regulated.
The appropriate terminal electron acceptor complex is
likely determined by the pervading oxygen tension, and
oxygen tension differs between different tissues in vivo.
Indeed, the growth of V. cholerae in rabbit ileal loops and
of P. multocida in liver indicated up-regulation of a num-
ber of genes expected to be regulated by anaerobiosis.
Again, these measurements have been compared with
growth in vitro in laboratory media so that anaerobiosis is
only defined by comparison with the (likely) highly aero-
bic in vitro environment.
These in vivo experiments have so far shown variable
expression of known virulence factors. In V. cholerae, in
which virulence factors are fairly well defined, a small
number of virulence factors were expressed in organisms
purified from rice water stools (21), including genes
involved in amino acid metabolism, purine metabolism,
and the acid tolerance response. None of the genes in the
ToxR/TcpP/ToxT virulence gene regulon was identified as
differentially expressed in this host niche, which indicates
that these genes are transiently expressed and are not nec-
essary as the bacteria are exiting the host. However, a num-
ber of virulence genes were expressed in bacteria grown in
rabbit ileal loops. Twelve of the top 300 expressed genes in
vivo were part of the pathogenesis functional group and
included the virulence regulators tcpP, tcpH and toxR, the
hemolysin and hemolysin transporter genes hlyA and hlyB,
and the hemagglutinin protease gene hapR. For P. multoci-
da, one third of the genes identified as virulence genes by
signature-tagged mutagenesis (26) were also identified as
differentially regulated during growth in the blood of
chickens.
Three studies of Borrelia burgdorferi have analyzed
gene expression during infection (Table). Two of these
analyzed whole-genome expression changes during
growth in dialysis membranes implanted in rat peritoneal
cavities (14,15), and one focused specifically on expres-
sion of lipoproteins during growth in mice (16). The gene
expression profiles observed differed substantially from
those observed for P. multocida and V. cholerae growing
in tissue. Few changes were observed in genes involved in
energy metabolism or in amino acid, carbohydrate, and
iron transport and metabolism. This finding may be a result
of the slow rate of B. burgdorferi growth in the mam-
malian environment. The most notable changes observed
in B. burgdorferi gene expression involved expression of
outer membrane components, particularly lipoproteins
(although one study analyzed only lipoprotein genes).
Thus, B. burgdorferi appears to respond primarily to the
host innate or adaptive immune system, or both, resulting
in the down-regulation of a large number of surface com-
ponents, including about 100 lipoproteins. 
For many human-specific pathogens, no well-defined
animal model exists; conducting gene expression studies
during real infections is thus very difficult or impossible.
One experimental method that has been used to overcome
this problem is analysis of gene expression in response to
interaction with host cells. Two studies have analyzed the
global transcriptional response of Neisseria species to
interaction with eukaryotic cells (Table). These studies of
Neisseria meningitidis and  N. lactamica compared
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Table. Large-scale measurement of bacterial gene or protein expression during real infections or interactions with host cells  
Species  Experiment type   Description  Reference 
Growth in the host        
Borrelia burgdorferi   DNA microarray   Growth in dialysis membranes implanted in rats   14 
  DNA microarray   Adaptation to growth in dialysis membranes in rats    15 
  DNA microarray   Alteration of lipoprotein expression during host adaptation in mice    16 
  Antigenic profiling   Alteration of antigenic profile during host adaptation in mice  17 
       
Pasteurella multocida    DNA microarray   Gene expression during growth in blood of infected chickens   18 
  DNA microarray   Gene expression during growth in livers of infected chickens   19 
       
Vibrio cholerae   DNA microarray   Gene expression during growth in rabbit ileal loops   20 
  DNA microarray   Gene expression in rice water stools   21 
Interaction with tissue   
culture cells 
     
Chlamydia pneumoniae   2-dimensional gel 
electrophoresis  
Protein expression during growth in HEp-2 cells in  
response to interferon-γ 
22 
Neisseria meningitidis   DNA microarray   Interaction with epithelial and endothelial cells   23 
  DNA microarray   Interaction with epithelial cells   24 expression profiles of bacteria in cell culture medium with
bacteria in contact with epithelial or endothelial cells
(23,24). The gene expression profiles observed in the two
studies showed substantial similarity. Similar to the find-
ings from the in vivo studies of V. cholerae and  P.
multocida (18–20), many up-regulated genes were identi-
fied that were involved in transport and energy metabo-
lism. A range of transporters were up-regulated, especially
those involved in amino acid and sulfate transport. Indeed,
the sulfate transport system, which is strictly linked to sul-
fur-containing amino acid metabolism, was up-regulated
in the pathogen (N. meningitidis) but not in the commensal
species (N. lactamica), which indicates that this factor may
play a role in virulence (24). The other major group of
genes that were up-regulated in the bacteria in contact with
host cells were those involved in adhesion. Many of these
have been previously characterized as virulence genes.
Comparing the in vivo studies with defined in vitro
studies may allow deconstruction of the stimuli acting in
the in vivo microenvironment. This possibility is a prom-
ising aspect of gene expression studies that has not yet
been fully explored. For example, in P. multocida grown
in chickens, the gene expression profile of bacteria within
two of three animals was similar to the genes observed to
be up-regulated under in vitro iron starvation. Such com-
parative analyses can expand our understanding of the
selective pressures acting on the pathogen during infec-
tion. In fact, this first analysis of P. multocida indicated
that in at least one of the infections, the bacterial gene
expression profile differed from that observed under iron-
limiting conditions, which suggests that a bacterial
response to low iron may occur only in some hosts or at
certain stages of infection.
Proteomic Studies
Proteomics refers to any global analysis of proteins.
Proteomics has the potential to show posttranslational
modifications, translational regulation, the products of
alternative splicing of mRNAs, and selective degradation
of proteins, all of which cannot be accounted for when
directly measuring mRNA transcript levels.
Although proteomic strategies abound, two main
approaches exist for analyzing complex protein mixtures,
each of which is quite distinct and possesses subtle advan-
tages and disadvantages. One method relies on the separa-
tion of whole proteins by two-dimensional gel
electrophoresis (2-DGE) and the subsequent identification
of individual proteins through mass spectrometry. The
other method, often referred to as multidimensional pro-
tein identification technology (MUDPIT), relies on the
separation of proteolytic peptides by liquid chromatogra-
phy and their identification by directly coupled electro-
spray ionization-tandem mass spectrometry. 
A number of technical problems limit the coverage of
proteomic analyses. Proteome analysis with 2-DGE often
excludes proteins that are large, hydrophobic, or have
extremely alkaline isoelectric points. Hydrophobic pro-
teins are often missed because of their insolubility during
isoelectric focusing, the problems in extracting hydropho-
bic peptides from gel matrices, and the difficulty in ioniz-
ing hydrophobic peptides for analysis by mass
spectrometry (28). Large or basic proteins are often not
resolved because they do not enter the isoelectric focusing
gradient or do not remain soluble during focusing. The
MUDPIT approach overcomes many of the limitations
imposed by the solubility difficulties encountered during
the isoelectric focusing step of 2-DGE. However, 2-D gels
provide a visual reference of protein expression for com-
parison, while also permitting the experimenter to observe
posttranslational modifications and protein cleavage
events, which would not be evident by using MUDPIT. In
addition, MUDPIT per se does not yield quantitative infor-
mation (29). 2-DGE and MUDPIT are complementary
technologies, and to achieve optimal coverage, both sys-
tems should be used (30). However, in contrast to mRNA-
based approaches, the current technologies are not capable
of elucidating the entire proteome.
Do data obtained by using microarray experiments cor-
relate with proteomic data collected from the same biolog-
ical system and should we expect them to? In a study
performed on yeast in which protein expression with
mRNAlevels were compared with those obtained by using
the serial analysis of gene expression technique, a correla-
tion coefficient of approximately 0.4 was obtained, which
indicated that protein expression levels correlated poorly
with quantitative mRNAdata (31). Amore global study, in
which mRNA levels obtained by microarray analysis were
compared with those obtained with protein expression lev-
els assessed by using a MUDPIT/isotope-coded affinity-
tag approach, found that the expression of mRNA and
protein sets involved in some biologic pathways were
highly correlated while others were not. This finding sug-
gests that posttranscriptional regulation mechanisms were
operating in those instances when protein expression lev-
els correlated poorly with quantitative mRNA data (32).
Thus, the lack of correlation reported by many researchers
(33–36) may result from technical hurdles associated with
accurately measuring either mRNA or protein expression
levels on a global scale. Nonetheless, if the tools used to
measure gene and protein expression are accurate, the
expression data should correlate for transcripts and pro-
teins that comprise biologic pathways not subject to post-
transcriptional or posttranslational regulation.
Using these proteomic methods to analyze bacterial
pathogens has substantial promise, but no example yet
exists of global protein expression analysis of a bacterial
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model. This situation has likely occurred because of the
technical hurdles associated with separating bacteria from
the host tissues and obtaining sufficient material to per-
form serial analyses required for statistical significance.
The problem of contaminating host tissue has probably
been overemphasized: small amounts of contaminating
host proteins should not compromise the separation and
can subsequently be withdrawn from the dataset when in
silico searches show a match with the host organism. Afar
greater problem is obtaining sufficient sample because no
techniques are available for signal amplification (as is the
case for mRNA expression analysis). Even when enough
material can be obtained, this will almost certainly be dur-
ing the end stages of infection, when the bacterial expres-
sion may not differ markedly in quantity from that
observed during growth in culture. To analyze global pro-
tein expression during the early stages of infection when
virulence factors are likely to be expressed, we must await
improvements in the technologies involved in separating
bacteria from the host and protein expression analysis sys-
tems that have improved sensitivity for use with small
amounts of sample.
Although no studies of bacterial protein expression
inside the host have been published, several investigators
have analyzed bacterial protein expression during growth
in vitro under conditions that mimic some aspect of infec-
tion. These studies have included the response to tempera-
ture change, iron-limitation, and the presence of serum
proteins (37), nutrient starvation (6), pH stress (38,39),
magnesium limitation (40), and biofilm formation (41,42).
Other studies have used cell culture systems to more close-
ly mimic the host environment. An analysis of whole cell
protein expression of Chlamydia pneumoniae (Table) dur-
ing growth in HEp-2 cells and in response to treatment
with interferon-γ was possible after radioactive labeling of
the bacteria (22). This analysis indicated up-regulation of
a small number of proteins involved in replication, energy
metabolism, and peptidoglycan synthesis. An antigen pro-
file analysis of B. burgdorferi allowed changes in the anti-
genic proteins expressed during growth in mice to be
compared with changes during growth in in vitro laborato-
ry medium (Table). This analysis allowed for the semi-
quantitative measurement of B. burgdorferi antigen
expression in different mouse tissues and showed the dif-
ferential expression of some known surface proteins (17)
However, this analysis falls short of a whole-genome study
because it can only measure antigenic proteins soluble in
Triton X-114. As technical hurdles are overcome, whole-
cell protein expression analysis of bacterial pathogens
growing inside the host is poised to provide substantial
insight into the mechanisms of bacterial pathogenesis. 
Conclusion
Techniques are now available to begin to meaningfully
analyze bacterial expression during growth within eukary-
otic hosts, and such studies will transform our understand-
ing of the molecular mechanisms of pathogenesis.
Although technical problems remain (such as how to cope
with the limited amount of material present during infec-
tion and how to purify the pathogens from the eukaryotic
host), methods are rapidly being developed to overcome or
circumvent these problems. In fact, the necessary further
advances will likely be gradual improvements in current
technologies rather than new technologies. However, the
new challenge may well become the analysis of the large
datasets that are generated and the seamless integration
with other genomic, proteomic, metabolic pathway, and
phenotype data. Integrating these data types will delineate
the pathogen’s response to the host and help clarify the
intricate cross-talk from host to pathogen and the environ-
mental cues and regulatory networks that lead to the
expression of bacterial virulence factors. Such a detailed
understanding of bacterial pathogens will likely ultimately
be available, and this knowledge will facilitate the design
of improved vaccines and the rational design of antimicro-
bial compounds. 
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